Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 46 to 60 of 713 results for diabet*

  1. Type 2 diabetes: insulin degludec (ESNM25)

    Summary of the evidence on insulin degludec for treating type 2 diabetes to inform local NHS planning and decision-making

    Evidence summary
    Published
    10 September 2013

  2. Type 2 diabetes in adults. Patient decision aid on type 2 diabetes: agreeing my blood glucose (HbA1c) target

    1 Type 2 diabetes: agreeing my blood glucose (HbA1c) target Patient decision aid c NICE 2022. All rights reserved. Subject to Notice of...

  3. NICE Fellowship project to facilitate the implementation of NICE guidance PH38 via the utilisation of Tier 2 and Tier 3 weight management and lifestyle-intervention programmes for the prevention of type 2 diabetes

    This project aimed to promote the implementation of NICE guidance PH38 utilising existing tier 2 and tier 3 weight management services, including commercial providers.

    Shared learning
    Published
    14 November 2017

  4. Supporting the management of type 2 diabetes with pharmacist-led reviews and implementing NICE recommended nine key care processes

    NICE-recommended 9 key care processes, or whose care processes indicated poor Type 2 Diabetes (T2D) control. The project aimed to reduce...

    Shared learning
    Last updated
    21 February 2018

  5. Tackling the overtreatment of type 2 diabetes in frail older people through individualising care in East Sussex: a pharmacist led project

    support primary care diabetes teams in working with patients to optimise prescribing through implementation of NICE guideline for...

    Shared learning
    Last updated
    7 April 2020

  6. Training non-podiatrists to assess foot risk as part of an integrated foot service for people with diabetes

    the necessary care and treatment for those at higher risk of developing diabetic foot problems. Those at low risk could be seen at the...

    Shared learning
    Published
    16 February 2016

  7. Empagliflozin in combination therapy for treating type 2 diabetes (TA336)

    Evidence-based recommendations on empagliflozin (Jardiance) in combination therapy for treating type 2 diabetes.

    Technology appraisal guidance
    Published
    25 March 2015
    View recommendations

    Sections for TA336

  8. Turning the tide on ineffective prescribing of glucagon like peptide (GLP-1) mimetics in type 2 diabetes in East Sussex

    November 2018 Spend on diabetes prescribing; in particular glucagon like peptide 1 (GLP-1) mimetics within

    Shared learning
    Last updated
    23 May 2019

  9. Young Adult Diabetes: Engaging to improve; outcomes of the young adult clinic restructure

    In accordance with NICE diabetes guidance NG17 and NG18, and in line with Quality Standard 140 on transition

    Shared learning
    Last updated
    16 December 2020

  10. Improving foot care outcomes for people with diabetes in Wessex

    Reducing the number of amputations among people living with diabetes in Wessex has been a key aim of the Wessex Cardiovascular Clinical...

    Shared learning
    Published
    22 March 2019

  11. Implementing multiple daily injection insulin regimens (MDI) with carbohydrate counting for children and young people at diagnosis of type 1 diabetes: education provided by the Children's Diabetes Service for patients, families and staff

    Oxfordshire Children's Diabetes Service offers comprehensive one-to one education around multiple-daily

    Shared learning
    Published
    6 April 2016

  12. PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes (MIB312)

    NICE has developed a medtech innovation briefing (MIB) on PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes .

    Medtech innovation briefing
    Published
    13 December 2022

  13. d-Nav insulin management app for type 2 diabetes (MIB285)

    NICE has developed a medtech innovation briefing (MIB) on d-Nav insulin management app for type 2 diabetes .

    Medtech innovation briefing
    Published
    8 February 2022

  14. NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds (MIB208)

    NICE has developed a medtech innovation briefing (MIB) on NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds .

    Medtech innovation briefing
    Published
    17 March 2020

  15. Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema (MIB144)

    NICE has developed a medtech innovation briefing (MIB) on Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema .

    Medtech innovation briefing
    Published
    24 April 2018